| Product Code: ETC11385294 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India antiarrhythmic drugs market import shipment exhibited a notable decline with a CAGR of -29.3% from 2020 to 2024. The growth rate between 2023 and 2024 decreased by -10.9%, indicating a continued slowdown in market expansion. The trend suggests a significant contraction in imports over the period, reflecting a challenging market environment.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Antiarrhythmic Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Antiarrhythmic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Antiarrhythmic Drugs Market - Industry Life Cycle |
3.4 India Antiarrhythmic Drugs Market - Porter's Five Forces |
3.5 India Antiarrhythmic Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Antiarrhythmic Drugs Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 India Antiarrhythmic Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Antiarrhythmic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in India |
4.2.2 Growing geriatric population in the country |
4.2.3 Rising adoption of advanced healthcare technologies and treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of antiarrhythmic drugs |
4.3.2 High cost associated with antiarrhythmic drug therapies |
4.3.3 Potential side effects and risks associated with prolonged use of antiarrhythmic drugs |
5 India Antiarrhythmic Drugs Market Trends |
6 India Antiarrhythmic Drugs Market, By Types |
6.1 India Antiarrhythmic Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Antiarrhythmic Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 India Antiarrhythmic Drugs Market Revenues & Volume, By Sodium Channel Blockers, 2021 - 2031F |
6.1.4 India Antiarrhythmic Drugs Market Revenues & Volume, By Beta Blockers, 2021 - 2031F |
6.1.5 India Antiarrhythmic Drugs Market Revenues & Volume, By Potassium Channel Blockers, 2021 - 2031F |
6.1.6 India Antiarrhythmic Drugs Market Revenues & Volume, By Calcium Channel Blockers, 2021 - 2031F |
6.2 India Antiarrhythmic Drugs Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 India Antiarrhythmic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.2.3 India Antiarrhythmic Drugs Market Revenues & Volume, By Ventricular Tachycardia, 2021 - 2031F |
6.2.4 India Antiarrhythmic Drugs Market Revenues & Volume, By Supraventricular Tachycardia, 2021 - 2031F |
6.2.5 India Antiarrhythmic Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 India Antiarrhythmic Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Antiarrhythmic Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 India Antiarrhythmic Drugs Market Revenues & Volume, By Cardiac Centers, 2021 - 2031F |
6.3.4 India Antiarrhythmic Drugs Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.5 India Antiarrhythmic Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 India Antiarrhythmic Drugs Market Import-Export Trade Statistics |
7.1 India Antiarrhythmic Drugs Market Export to Major Countries |
7.2 India Antiarrhythmic Drugs Market Imports from Major Countries |
8 India Antiarrhythmic Drugs Market Key Performance Indicators |
8.1 Number of new product innovations in the antiarrhythmic drugs market in India |
8.2 Percentage increase in the adoption of antiarrhythmic drugs among healthcare providers |
8.3 Patient adherence rate to prescribed antiarrhythmic drug treatments |
9 India Antiarrhythmic Drugs Market - Opportunity Assessment |
9.1 India Antiarrhythmic Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Antiarrhythmic Drugs Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 India Antiarrhythmic Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Antiarrhythmic Drugs Market - Competitive Landscape |
10.1 India Antiarrhythmic Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Antiarrhythmic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here